SCOTTSDALE, Ariz.—Novo Solutions MD® launched its science-based skin care line containing NovoSerum™, a proprietary cell-free complex derived from purified human umbilical cord serum, among other natural ingredients. NovoSerum was co-developed by Mark R. Engelman M.D., the former medical director and Ccairman of the Department of Emergency Medicine at St. Joseph Hospital in Phoenix, and Richard L. Johnes, an entrepreneur and developer of luxury real estate brands. Alvin D. Needleman BSc, Reg. Pharm, is the formulator of the skin care line and is based in Las Vegas. It is free of cellular material and rigorously tested to FDA standards.
“Our research in the regenerative qualities of human umbilical cord serum reinforced what we already theorized—that the serum is an effective anti-ager that prompts the skin’s factory cells to increase natural collagen production and enhance skin matrix, the essential elements which give the skin structure, fullness and radiance," explains Dr. Engelman, whose work as a medical business consultant for stem cell therapy companies led him to become an expert in anti-aging and regenerative medicine.
Reinforcing the science of NovoSerum are the results of an independent double-blind clinical study conducted in 2010 by Robert M. Lavker Ph.D., professor of dermatology and director of dermatology research at Northwestern University. In the study, skin treated with NovoSerum was found to have a significant increase in collagen and skin matrix production.
Among the natural ingredients in Novo Solutions MD products, such as bioactive antioxidants, botanical alpha hydroxy acid (AHA) complex and milk lipids, are the latest neuro-peptides that relax the face. The bioactive antioxidants significantly reduce and counteract external, environmental and internally produced skin aging elements.
Six exclusive products for women and men include Absolute Face Cleanser, Brilliant Face Exfoliant, Cellactive Face Serum, Advanced Eye Serum, Moisturizing Renewal Cream and Moisturizing Renewal Cream with SPF 15.